SlideShare uma empresa Scribd logo
1 de 39
ASTER One Year Later
A New Business Model for
Postmarketing Reporting
Session Participants
• Michael Ibara (Pfizer)
  – Setting the stage
  – ASTER

• Landen Bain (CDISC Liaison to Healthcare)
  – Experiences in ASTER
  – Reflections on role of not for profits

• Atif Zafar, MD (Associate Professor of Medicine,
  Indiana University / Regenstrief Institute Inc.)
  – Reporting events and patient outcomes related to
    therapy

• Lise Stevens (Data Standards Project Manager,
  FDA Office of Critical Path Programs)
  – FDA’s work
  – Results
1993 to 2009
“Unfortunately, many health professionals do
  not think to report adverse events that might

              16 YEARS
  be associated with medications or devices to
  the Food and Drug Administration (FDA) or to
  the manufacturer. That needs to change...”

     Introducing MEDWatch: A New Approach to Reporting Medication and Device
                                        Adverse Effects and Product Problems
                                 David A. Kessler, MD, for the Working Group

                                       JAMA, June 2,   1993   Vol 269, No. 21
10:30:00
In the greater metro Boston area, a doctor
affiliated with Brigham and Women’s
Hospital or Mass General Hospital
discontinues a patient’s drug due to an
adverse event.
If the doctor is participating in a certain
effort, here’s what will happen…
Screen Shots
Screen shots #2
Screen shots #3
Screen shots #4
Screen shots #5
Screen shots #6
Screen shots #7
10:31:00
           10:30:00
The doctor goes back to seeing the patient
10:40:00
A MedWatch report* derived directly from
the source document (EHR), validated by
the doctor, is delivered to FDA

*The report is MedDRA coded and has an initial
‘serious/nonserious’ assessment
Improving The Reporting of Adverse
Events and Making Spontaneous
Reporting Work
The ASTER Collaboration…

    Partners Healthcare

          CDISC

      CRIX / CERNER

           FDA

           Pfizer
Scalable Model for “Triggered” Reporting
      Computer-assisted Surveillance                 •   Data collection incorporated
                                                         at point of care
                                                     •   Very light footprint for EMR
                                      EHR            •   Portable to other EMRs,
                                                         applications
                                                     •   Can take advantage of
  Provider / Patient                                     further developments in
                                                         automated recognition
                                                     •   Global solution
• Structured by safety elements
requirements (E2B/HL7 ICSR)

• Mediated through RFD, Web
Forms

                                                                       Manufacturers


                                  Public / Private
                                  Organization
                                                                  Regulators            15
HOW DID IT
GO?
*ASTER started Nov 2008
  30 Ambulatory care physicians
  Completing June 2009
  > 200 Reports Sent to FDA

David Westfall Bates, MD, M.Sc.
Chief of the Division of General Internal Medicine at the Brigham and Women's
Hospital; Professor of Medicine at Harvard Medical School and Professor of
Health Policy and Management at the Harvard School of Public Health (Co-
Director of the Program in Clinical Effectiveness)

Jeffrey A. Linder, MD, MPH, FACP - PI of *ASTER
Assistant Professor of Medicine, Harvard Medical School
Division of General Medicine and Primary Care, Brigham and Women's Hospital,
Boston MA
RESULTS TO DATE
...Physician interaction – ”a blink (60 secs)”

...time for reviewing instructions - no instructions needed

...searching existing data sources - no searching required

...gathering and maintaining the data needed - transparent

...completing and reviewing the information - minimal interaction
In f o r m a t io n in R e p o r t s
• Approximately 20% of reported events
were deemed ‘Serious’ defined as:
   • Matching regulatory serious
     outcome
   • Coded event matching an ‘always
     serious list’
• 100% had height/weight, lab data
P h y s ic ia n R e p o r t in g
• 91% of participating physicians had
submitted no ADE reports in the prior year
• During the study, participants reported an
average of approximately 5 reports in a 3
month time period
• All participants reported at least 1 ADE
P h y s ic ia n A c c e p t a n c e
What could make it better?
• Majority would like feedback from FDA
   • e.g., Actions taken on the report
   • e.g., Acknowledgement of report
• Vast majority would like to be able to
view national data of similar reports
• 87% thought ASTER would improve
their ability to accurately report drug
risks “a lot”
D is lik e s …
“Took a while for the screen
  to pop up”
“Too many clicks, screen too
  slow”
“Takes a little extra time, but
  worth it”
L ik e s …
“Easy, pops right up - Nothing
  to do later, can do it right
  on the spot.”
“very quick, automatic load”
“help to pt safety”
"Overall ASTER was well-accepted by the
  participating physicians, who felt it was
  unobtrusive and who saw the public health
  potential.
“The clinicians, most of whom submitted no
  reports in the prior year - submitted over
  200 reports in 3 months."

               Jeffrey A. Linder, MD, MPH, FACP
  Brigham and Women’s Hospital / Partners Healthcare
                                   PI on ASTER Study
“Unfortunately, many health professionals do
  not think to report adverse events that might
  be associated with medications or devices to
  the Food and Drug Administration (FDA) or to
  the manufacturer. That needs to change...”

     Introducing MEDWatch: A New Approach to Reporting Medication and Device
                                        Adverse Effects and Product Problems
                                 David A. Kessler, MD, for the Working Group

                                       JAMA, June 2,   1993   Vol 269, No. 21
Herbert Simon
                                                                       Richard King Mellon University
                                                                       Professor of Computer Science and
                                                                       Psychology at Carnegie Mellon
                                                                       University (b. Milwaukee 1916 - d.
                                                                       Pittsburgh 2001)
                                                                       52-year career in artificial
                                                                       intelligence, psychology,
                                                                       administration and economics.
                                                                       Nobel Prize Economics


1975: Won A.M. Turing Award for his work in computer science
1978: Received the Alfred Nobel Memorial Prize in Economic Sciences
1986: National Medal of Science
1993: American Psychological Association Award for Outstanding Lifetime Contributions to Psychology
1994: One of only 14 foreign scientists ever to be inducted into the Chinese Academy of Sciences
1995: Two prominent awards - International Joint Conferences on Artificial Intelligence (the Award for Research
Excellence) and the American Society of Public Administration (the Dwight Waldo Award)
1996: Inducted into the Automation Hall of Fame because of his pioneering work in the field of artificial intelligence
Received major national awards from the Association for Computing Machinery, the American Political Science
Association, the Academy of Management, the Operations Research Society and the Institute of Management Science,
among others.

Books include Administrative Behavior; Human Problem Solving, jointly with Allen Newell; The Sciences of the Artificial;
Scientific Discovery, with Pat Langley, Gary Bradshaw, and Jan Zytkow; Models of Bounded Rationality; Models of
Thought; Models of Discovery; and his autobiography, Models of My Life.
"What
“What information consumes is rather obvious: it
  consumes the attention of its recipients. Hence a
  wealth of information creates a poverty of
  attention
  attention, and a need to allocate that attention
  efficiently among the overabundance of
  information sources that might consume it."
     Simon, H. A. (1971), "Designing Organizations for an Information-Rich World", written
        at Baltimore, MD, in Martin Greenberger, Computers, Communication, and the
        Public Interest, The Johns Hopkins Press, ISBN 0-8018-1135-X
"A design representation suitable to a
world in which the scarce factor is
information may be exactly the wrong one
for a world in which the scarce factor is
attention.”

                                   Herbert Simon
                       The Sciences of the Artificial
                                             p.144
"A design representation suitable to a
world in which the scarce factor is
information may be exactly the wrong one
              the scarce
for a world in which
factor is attention.
The task is not to design information-
distributing systems but intelligent
information-filtering systems.“


                                   Herbert Simon
                       The Sciences of the Artificial
                                             p.144
We need
                business
We’ve           models that
electronified   will take
our old         advantage of
business        digitized
model           healthcare
                data
Scalable Model for “Triggered” Reporting
   Computer-assisted Surveillance


                             EHR


Provider / Patient




                                                Manufacturers


                         Public / Private
                         Organization
                                            Regulators     15
What does ASTER solve?

    Problems for…
    The reporter
    The EHR owner
    The Regulator*

    *and manufacturer
Does this matter…
Imagine…
 Collecting all drug discontinuations
 due to AEs…

 Interfacing seamlessly with any
 clinical system using ‘triggers’ to
 recognize AEs…
 Having as much safety data from
 source docs as we do claims data…
 Having a denominator from each
 reporting institution…
This is not your
fathers spontaneous
reporting…
By utilizing digitized healthcare data
and new business models we can
develop, in the near future, a new
type of ‘triggered reporting’ system,
which is pervasive, efficient, delivers
high quality information, and
improves patient safety.

Mais conteúdo relacionado

Mais procurados

IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine Learning
IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine LearningIRJET - Chronic Kidney Disease Prediction using Data Mining and Machine Learning
IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine LearningIRJET Journal
 
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes Technique
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes TechniqueIRJET- Chronic Kidney Disease Prediction based on Naive Bayes Technique
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes TechniqueIRJET Journal
 
Complex Health Data Visualization
Complex Health Data VisualizationComplex Health Data Visualization
Complex Health Data VisualizationNicholas Tenhue
 
Data Visuallization for Decision Making - Intel White Paper
Data Visuallization for Decision Making - Intel White PaperData Visuallization for Decision Making - Intel White Paper
Data Visuallization for Decision Making - Intel White PaperNicholas Tenhue
 
Recent advances and challenges of digital mental healthcare
Recent advances and challenges of digital mental healthcareRecent advances and challenges of digital mental healthcare
Recent advances and challenges of digital mental healthcareYoon Sup Choi
 
Data Analytics Project proposal: Smart home based ambient assisted living - D...
Data Analytics Project proposal: Smart home based ambient assisted living - D...Data Analytics Project proposal: Smart home based ambient assisted living - D...
Data Analytics Project proposal: Smart home based ambient assisted living - D...Tarun Swarup
 
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...Artificial Intelligence Institute at UofSC
 
Drive Clinical and Financial Performance with McKesson Anesthesia Care
Drive Clinical and Financial Performance with McKesson Anesthesia CareDrive Clinical and Financial Performance with McKesson Anesthesia Care
Drive Clinical and Financial Performance with McKesson Anesthesia CareMcKesson Surgical Solutions
 
Dark Side and Bright Side of AI in Medicine
Dark Side and Bright Side of AI in MedicineDark Side and Bright Side of AI in Medicine
Dark Side and Bright Side of AI in MedicineUniversity of Florida
 
Intelligent data analysis for medicinal diagnosis
Intelligent data analysis for medicinal diagnosisIntelligent data analysis for medicinal diagnosis
Intelligent data analysis for medicinal diagnosisIRJET Journal
 
Hinf6230 Technology Assessment Gideon Presentation Abel Sunil
Hinf6230 Technology Assessment Gideon Presentation Abel SunilHinf6230 Technology Assessment Gideon Presentation Abel Sunil
Hinf6230 Technology Assessment Gideon Presentation Abel SunilAbel Gebreyesus
 
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostAnalytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostCognizant
 
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...Nawanan Theera-Ampornpunt
 
Digital Health Transformation (March 16, 2019)
Digital Health Transformation (March 16, 2019)Digital Health Transformation (March 16, 2019)
Digital Health Transformation (March 16, 2019)Nawanan Theera-Ampornpunt
 
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di Tada
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di TadaBiosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di Tada
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di TadaTaha Kass-Hout, MD, MS
 

Mais procurados (20)

IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine Learning
IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine LearningIRJET - Chronic Kidney Disease Prediction using Data Mining and Machine Learning
IRJET - Chronic Kidney Disease Prediction using Data Mining and Machine Learning
 
Menzies final hobart 29 feb13
Menzies final hobart 29 feb13Menzies final hobart 29 feb13
Menzies final hobart 29 feb13
 
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes Technique
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes TechniqueIRJET- Chronic Kidney Disease Prediction based on Naive Bayes Technique
IRJET- Chronic Kidney Disease Prediction based on Naive Bayes Technique
 
Complex Health Data Visualization
Complex Health Data VisualizationComplex Health Data Visualization
Complex Health Data Visualization
 
Data Visuallization for Decision Making - Intel White Paper
Data Visuallization for Decision Making - Intel White PaperData Visuallization for Decision Making - Intel White Paper
Data Visuallization for Decision Making - Intel White Paper
 
Recent advances and challenges of digital mental healthcare
Recent advances and challenges of digital mental healthcareRecent advances and challenges of digital mental healthcare
Recent advances and challenges of digital mental healthcare
 
Data Analytics Project proposal: Smart home based ambient assisted living - D...
Data Analytics Project proposal: Smart home based ambient assisted living - D...Data Analytics Project proposal: Smart home based ambient assisted living - D...
Data Analytics Project proposal: Smart home based ambient assisted living - D...
 
1 9
1 91 9
1 9
 
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...
Knowledge-driven Personalized Contextual mHealth Service for Asthma Managemen...
 
Drive Clinical and Financial Performance with McKesson Anesthesia Care
Drive Clinical and Financial Performance with McKesson Anesthesia CareDrive Clinical and Financial Performance with McKesson Anesthesia Care
Drive Clinical and Financial Performance with McKesson Anesthesia Care
 
iPad for (tele)radiology, a critical appraisal
iPad for (tele)radiology, a critical appraisaliPad for (tele)radiology, a critical appraisal
iPad for (tele)radiology, a critical appraisal
 
Dark Side and Bright Side of AI in Medicine
Dark Side and Bright Side of AI in MedicineDark Side and Bright Side of AI in Medicine
Dark Side and Bright Side of AI in Medicine
 
Intelligent data analysis for medicinal diagnosis
Intelligent data analysis for medicinal diagnosisIntelligent data analysis for medicinal diagnosis
Intelligent data analysis for medicinal diagnosis
 
Hinf6230 Technology Assessment Gideon Presentation Abel Sunil
Hinf6230 Technology Assessment Gideon Presentation Abel SunilHinf6230 Technology Assessment Gideon Presentation Abel Sunil
Hinf6230 Technology Assessment Gideon Presentation Abel Sunil
 
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostAnalytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
 
50120140506011
5012014050601150120140506011
50120140506011
 
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...
IT Governance & Management in Healthcare Organizations: Part 2 (October 19, 2...
 
Digital Health Transformation (March 16, 2019)
Digital Health Transformation (March 16, 2019)Digital Health Transformation (March 16, 2019)
Digital Health Transformation (March 16, 2019)
 
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di Tada
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di TadaBiosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di Tada
Biosurveillance: Machine Learning And Disease Surveillance by Kass-Hout Di Tada
 
Eliminating Harm
Eliminating Harm Eliminating Harm
Eliminating Harm
 

Destaque

DM Healthcare - Growth Profile
DM Healthcare - Growth Profile DM Healthcare - Growth Profile
DM Healthcare - Growth Profile Yashaswini Agarwal
 
Branding for Aster Medcity- A Branding Case
Branding for Aster Medcity- A Branding CaseBranding for Aster Medcity- A Branding Case
Branding for Aster Medcity- A Branding CaseAbraham Isaac
 
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communication
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communicationMANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communication
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communicationSwati Iyer
 
My Internship Report
My Internship ReportMy Internship Report
My Internship ReportAbid Hussain
 
Apollo hospital project enjoy guys whatsapp on 9945547941
Apollo hospital project enjoy guys whatsapp on 9945547941Apollo hospital project enjoy guys whatsapp on 9945547941
Apollo hospital project enjoy guys whatsapp on 9945547941Umer Khan
 
Apollo internship report. final
Apollo internship report.   finalApollo internship report.   final
Apollo internship report. finalVivek Kulkarni
 
Operation theatre services
Operation theatre servicesOperation theatre services
Operation theatre servicesNc Das
 
Engineering hazards
Engineering hazardsEngineering hazards
Engineering hazardsNc Das
 
Hospital project report
Hospital project reportHospital project report
Hospital project reportjssclinic
 

Destaque (12)

Meeting minutes 2
Meeting minutes 2Meeting minutes 2
Meeting minutes 2
 
DM Healthcare - Growth Profile
DM Healthcare - Growth Profile DM Healthcare - Growth Profile
DM Healthcare - Growth Profile
 
Branding for Aster Medcity- A Branding Case
Branding for Aster Medcity- A Branding CaseBranding for Aster Medcity- A Branding Case
Branding for Aster Medcity- A Branding Case
 
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communication
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communicationMANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communication
MANAGEMENT TRAINEE PROGRAM PROJECTS AND OUTCOMES-brand and communication
 
My Internship Report
My Internship ReportMy Internship Report
My Internship Report
 
Apollo hospital project enjoy guys whatsapp on 9945547941
Apollo hospital project enjoy guys whatsapp on 9945547941Apollo hospital project enjoy guys whatsapp on 9945547941
Apollo hospital project enjoy guys whatsapp on 9945547941
 
Apollo internship report. final
Apollo internship report.   finalApollo internship report.   final
Apollo internship report. final
 
Operation theater
Operation theaterOperation theater
Operation theater
 
Operation theatre services
Operation theatre servicesOperation theatre services
Operation theatre services
 
Engineering hazards
Engineering hazardsEngineering hazards
Engineering hazards
 
Hospital project report
Hospital project reportHospital project report
Hospital project report
 
Apollo Hospitals
Apollo HospitalsApollo Hospitals
Apollo Hospitals
 

Semelhante a ASTER One Year Later: A Scalable Model for Triggered Reporting

China Annual Drug Information Association Meeting
China Annual Drug Information Association MeetingChina Annual Drug Information Association Meeting
China Annual Drug Information Association MeetingMichael Ibara
 
Social Media in Pharma Summit 2011: Drug Safety
Social Media in Pharma Summit 2011: Drug SafetySocial Media in Pharma Summit 2011: Drug Safety
Social Media in Pharma Summit 2011: Drug SafetyMichael Ibara
 
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...SharpBrains
 
Digital Health Transformation for Health Executives (January 18, 2022)
Digital Health Transformation for Health Executives (January 18, 2022)Digital Health Transformation for Health Executives (January 18, 2022)
Digital Health Transformation for Health Executives (January 18, 2022)Nawanan Theera-Ampornpunt
 
Digital Health 101 for Hospital Executives (October 4, 2021)
Digital Health 101 for Hospital Executives (October 4, 2021)Digital Health 101 for Hospital Executives (October 4, 2021)
Digital Health 101 for Hospital Executives (October 4, 2021)Nawanan Theera-Ampornpunt
 
Is Big Data Always Good Data?
Is Big Data Always Good Data? Is Big Data Always Good Data?
Is Big Data Always Good Data? MyMeds&Me
 
Digital healthcare show - How will Artificial Intelligence in healthcare will...
Digital healthcare show - How will Artificial Intelligence in healthcare will...Digital healthcare show - How will Artificial Intelligence in healthcare will...
Digital healthcare show - How will Artificial Intelligence in healthcare will...Dom Cushnan
 
Group powerpoint nur3563 team#3
Group powerpoint nur3563 team#3Group powerpoint nur3563 team#3
Group powerpoint nur3563 team#3nur3563Team3
 
Clinical information system
Clinical information systemClinical information system
Clinical information systemNUR3563Team1
 
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...MedTechAssociation
 
Integrating evidence based medicine and em rs
Integrating evidence based medicine and em rsIntegrating evidence based medicine and em rs
Integrating evidence based medicine and em rsTrimed Media Group
 
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...Pei-Yun Sabrina Hsueh
 
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...Health IT Conference – iHT2
 
Machine learning applied in health
Machine learning applied in healthMachine learning applied in health
Machine learning applied in healthBig Data Colombia
 

Semelhante a ASTER One Year Later: A Scalable Model for Triggered Reporting (20)

China Annual Drug Information Association Meeting
China Annual Drug Information Association MeetingChina Annual Drug Information Association Meeting
China Annual Drug Information Association Meeting
 
Social Media in Pharma Summit 2011: Drug Safety
Social Media in Pharma Summit 2011: Drug SafetySocial Media in Pharma Summit 2011: Drug Safety
Social Media in Pharma Summit 2011: Drug Safety
 
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
 
Digital Health Transformation for Health Executives (January 18, 2022)
Digital Health Transformation for Health Executives (January 18, 2022)Digital Health Transformation for Health Executives (January 18, 2022)
Digital Health Transformation for Health Executives (January 18, 2022)
 
Digital Health 101 for Hospital Executives (October 4, 2021)
Digital Health 101 for Hospital Executives (October 4, 2021)Digital Health 101 for Hospital Executives (October 4, 2021)
Digital Health 101 for Hospital Executives (October 4, 2021)
 
Is Big Data Always Good Data?
Is Big Data Always Good Data? Is Big Data Always Good Data?
Is Big Data Always Good Data?
 
Day 1: Real-World Data Panel
Day 1: Real-World Data Panel Day 1: Real-World Data Panel
Day 1: Real-World Data Panel
 
Digital healthcare show - How will Artificial Intelligence in healthcare will...
Digital healthcare show - How will Artificial Intelligence in healthcare will...Digital healthcare show - How will Artificial Intelligence in healthcare will...
Digital healthcare show - How will Artificial Intelligence in healthcare will...
 
Pavia wsp october 2011
Pavia wsp october 2011Pavia wsp october 2011
Pavia wsp october 2011
 
Nurses and Data Science
Nurses and Data ScienceNurses and Data Science
Nurses and Data Science
 
Group powerpoint nur3563 team#3
Group powerpoint nur3563 team#3Group powerpoint nur3563 team#3
Group powerpoint nur3563 team#3
 
Advancing-OSHMS High-Performance WS in OHM
Advancing-OSHMS High-Performance WS in OHMAdvancing-OSHMS High-Performance WS in OHM
Advancing-OSHMS High-Performance WS in OHM
 
Clinical information system
Clinical information systemClinical information system
Clinical information system
 
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...
MEDTECH 2013 Closing Plenary, Andy Shaudt, Director of Usability Services, Na...
 
Integrating evidence based medicine and em rs
Integrating evidence based medicine and em rsIntegrating evidence based medicine and em rs
Integrating evidence based medicine and em rs
 
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...
Mie2014 workshop: Gap Analysis of Personalized Health Services through Patien...
 
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...
Health IT Summit Austin 2013 - Presentation "The Impact of All Data on Health...
 
Machine learning applied in health
Machine learning applied in healthMachine learning applied in health
Machine learning applied in health
 
Rise of the Machines
Rise of the Machines  Rise of the Machines
Rise of the Machines
 
HIKM 2012 presentation fjms
HIKM 2012 presentation fjmsHIKM 2012 presentation fjms
HIKM 2012 presentation fjms
 

Mais de Michael Ibara

Ibara e source_final_1 posted
Ibara e source_final_1 postedIbara e source_final_1 posted
Ibara e source_final_1 postedMichael Ibara
 
2016 dia pv ibara final distribution
2016 dia pv ibara final distribution2016 dia pv ibara final distribution
2016 dia pv ibara final distributionMichael Ibara
 
2016 06 27 dia ibara e_source final distribution
2016 06 27 dia ibara e_source final distribution2016 06 27 dia ibara e_source final distribution
2016 06 27 dia ibara e_source final distributionMichael Ibara
 
eSource Stakeholders Group 18mar2016
eSource Stakeholders Group  18mar2016eSource Stakeholders Group  18mar2016
eSource Stakeholders Group 18mar2016Michael Ibara
 
Safety and Social Media Dia webinar 12 sep2013
Safety and Social Media Dia webinar 12 sep2013 Safety and Social Media Dia webinar 12 sep2013
Safety and Social Media Dia webinar 12 sep2013 Michael Ibara
 
Dia 16 jan 2013 ibara final posted
Dia 16 jan 2013 ibara final postedDia 16 jan 2013 ibara final posted
Dia 16 jan 2013 ibara final postedMichael Ibara
 
Social media and Pharmacovigilance
Social media and Pharmacovigilance Social media and Pharmacovigilance
Social media and Pharmacovigilance Michael Ibara
 
Aster ibara post approvalsummit final
Aster ibara post approvalsummit finalAster ibara post approvalsummit final
Aster ibara post approvalsummit finalMichael Ibara
 
Ibara Michael Aster Ppt Show
Ibara Michael Aster Ppt ShowIbara Michael Aster Ppt Show
Ibara Michael Aster Ppt ShowMichael Ibara
 

Mais de Michael Ibara (9)

Ibara e source_final_1 posted
Ibara e source_final_1 postedIbara e source_final_1 posted
Ibara e source_final_1 posted
 
2016 dia pv ibara final distribution
2016 dia pv ibara final distribution2016 dia pv ibara final distribution
2016 dia pv ibara final distribution
 
2016 06 27 dia ibara e_source final distribution
2016 06 27 dia ibara e_source final distribution2016 06 27 dia ibara e_source final distribution
2016 06 27 dia ibara e_source final distribution
 
eSource Stakeholders Group 18mar2016
eSource Stakeholders Group  18mar2016eSource Stakeholders Group  18mar2016
eSource Stakeholders Group 18mar2016
 
Safety and Social Media Dia webinar 12 sep2013
Safety and Social Media Dia webinar 12 sep2013 Safety and Social Media Dia webinar 12 sep2013
Safety and Social Media Dia webinar 12 sep2013
 
Dia 16 jan 2013 ibara final posted
Dia 16 jan 2013 ibara final postedDia 16 jan 2013 ibara final posted
Dia 16 jan 2013 ibara final posted
 
Social media and Pharmacovigilance
Social media and Pharmacovigilance Social media and Pharmacovigilance
Social media and Pharmacovigilance
 
Aster ibara post approvalsummit final
Aster ibara post approvalsummit finalAster ibara post approvalsummit final
Aster ibara post approvalsummit final
 
Ibara Michael Aster Ppt Show
Ibara Michael Aster Ppt ShowIbara Michael Aster Ppt Show
Ibara Michael Aster Ppt Show
 

ASTER One Year Later: A Scalable Model for Triggered Reporting

  • 1. ASTER One Year Later A New Business Model for Postmarketing Reporting
  • 2. Session Participants • Michael Ibara (Pfizer) – Setting the stage – ASTER • Landen Bain (CDISC Liaison to Healthcare) – Experiences in ASTER – Reflections on role of not for profits • Atif Zafar, MD (Associate Professor of Medicine, Indiana University / Regenstrief Institute Inc.) – Reporting events and patient outcomes related to therapy • Lise Stevens (Data Standards Project Manager, FDA Office of Critical Path Programs) – FDA’s work – Results
  • 3. 1993 to 2009 “Unfortunately, many health professionals do not think to report adverse events that might 16 YEARS be associated with medications or devices to the Food and Drug Administration (FDA) or to the manufacturer. That needs to change...” Introducing MEDWatch: A New Approach to Reporting Medication and Device Adverse Effects and Product Problems David A. Kessler, MD, for the Working Group JAMA, June 2, 1993 Vol 269, No. 21
  • 4.
  • 5. 10:30:00 In the greater metro Boston area, a doctor affiliated with Brigham and Women’s Hospital or Mass General Hospital discontinues a patient’s drug due to an adverse event. If the doctor is participating in a certain effort, here’s what will happen…
  • 13. 10:31:00 10:30:00 The doctor goes back to seeing the patient
  • 14. 10:40:00 A MedWatch report* derived directly from the source document (EHR), validated by the doctor, is delivered to FDA *The report is MedDRA coded and has an initial ‘serious/nonserious’ assessment
  • 15. Improving The Reporting of Adverse Events and Making Spontaneous Reporting Work
  • 16. The ASTER Collaboration… Partners Healthcare CDISC CRIX / CERNER FDA Pfizer
  • 17. Scalable Model for “Triggered” Reporting Computer-assisted Surveillance • Data collection incorporated at point of care • Very light footprint for EMR EHR • Portable to other EMRs, applications • Can take advantage of Provider / Patient further developments in automated recognition • Global solution • Structured by safety elements requirements (E2B/HL7 ICSR) • Mediated through RFD, Web Forms Manufacturers Public / Private Organization Regulators 15
  • 19. *ASTER started Nov 2008 30 Ambulatory care physicians Completing June 2009 > 200 Reports Sent to FDA David Westfall Bates, MD, M.Sc. Chief of the Division of General Internal Medicine at the Brigham and Women's Hospital; Professor of Medicine at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health (Co- Director of the Program in Clinical Effectiveness) Jeffrey A. Linder, MD, MPH, FACP - PI of *ASTER Assistant Professor of Medicine, Harvard Medical School Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston MA
  • 20. RESULTS TO DATE ...Physician interaction – ”a blink (60 secs)” ...time for reviewing instructions - no instructions needed ...searching existing data sources - no searching required ...gathering and maintaining the data needed - transparent ...completing and reviewing the information - minimal interaction
  • 21. In f o r m a t io n in R e p o r t s • Approximately 20% of reported events were deemed ‘Serious’ defined as: • Matching regulatory serious outcome • Coded event matching an ‘always serious list’ • 100% had height/weight, lab data
  • 22. P h y s ic ia n R e p o r t in g • 91% of participating physicians had submitted no ADE reports in the prior year • During the study, participants reported an average of approximately 5 reports in a 3 month time period • All participants reported at least 1 ADE
  • 23. P h y s ic ia n A c c e p t a n c e What could make it better? • Majority would like feedback from FDA • e.g., Actions taken on the report • e.g., Acknowledgement of report • Vast majority would like to be able to view national data of similar reports • 87% thought ASTER would improve their ability to accurately report drug risks “a lot”
  • 24. D is lik e s … “Took a while for the screen to pop up” “Too many clicks, screen too slow” “Takes a little extra time, but worth it”
  • 25. L ik e s … “Easy, pops right up - Nothing to do later, can do it right on the spot.” “very quick, automatic load” “help to pt safety”
  • 26. "Overall ASTER was well-accepted by the participating physicians, who felt it was unobtrusive and who saw the public health potential. “The clinicians, most of whom submitted no reports in the prior year - submitted over 200 reports in 3 months." Jeffrey A. Linder, MD, MPH, FACP Brigham and Women’s Hospital / Partners Healthcare PI on ASTER Study
  • 27. “Unfortunately, many health professionals do not think to report adverse events that might be associated with medications or devices to the Food and Drug Administration (FDA) or to the manufacturer. That needs to change...” Introducing MEDWatch: A New Approach to Reporting Medication and Device Adverse Effects and Product Problems David A. Kessler, MD, for the Working Group JAMA, June 2, 1993 Vol 269, No. 21
  • 28.
  • 29. Herbert Simon Richard King Mellon University Professor of Computer Science and Psychology at Carnegie Mellon University (b. Milwaukee 1916 - d. Pittsburgh 2001) 52-year career in artificial intelligence, psychology, administration and economics. Nobel Prize Economics 1975: Won A.M. Turing Award for his work in computer science 1978: Received the Alfred Nobel Memorial Prize in Economic Sciences 1986: National Medal of Science 1993: American Psychological Association Award for Outstanding Lifetime Contributions to Psychology 1994: One of only 14 foreign scientists ever to be inducted into the Chinese Academy of Sciences 1995: Two prominent awards - International Joint Conferences on Artificial Intelligence (the Award for Research Excellence) and the American Society of Public Administration (the Dwight Waldo Award) 1996: Inducted into the Automation Hall of Fame because of his pioneering work in the field of artificial intelligence Received major national awards from the Association for Computing Machinery, the American Political Science Association, the Academy of Management, the Operations Research Society and the Institute of Management Science, among others. Books include Administrative Behavior; Human Problem Solving, jointly with Allen Newell; The Sciences of the Artificial; Scientific Discovery, with Pat Langley, Gary Bradshaw, and Jan Zytkow; Models of Bounded Rationality; Models of Thought; Models of Discovery; and his autobiography, Models of My Life.
  • 30. "What “What information consumes is rather obvious: it consumes the attention of its recipients. Hence a wealth of information creates a poverty of attention attention, and a need to allocate that attention efficiently among the overabundance of information sources that might consume it." Simon, H. A. (1971), "Designing Organizations for an Information-Rich World", written at Baltimore, MD, in Martin Greenberger, Computers, Communication, and the Public Interest, The Johns Hopkins Press, ISBN 0-8018-1135-X
  • 31. "A design representation suitable to a world in which the scarce factor is information may be exactly the wrong one for a world in which the scarce factor is attention.” Herbert Simon The Sciences of the Artificial p.144
  • 32. "A design representation suitable to a world in which the scarce factor is information may be exactly the wrong one the scarce for a world in which factor is attention. The task is not to design information- distributing systems but intelligent information-filtering systems.“ Herbert Simon The Sciences of the Artificial p.144
  • 33. We need business We’ve models that electronified will take our old advantage of business digitized model healthcare data
  • 34. Scalable Model for “Triggered” Reporting Computer-assisted Surveillance EHR Provider / Patient Manufacturers Public / Private Organization Regulators 15
  • 35. What does ASTER solve? Problems for… The reporter The EHR owner The Regulator* *and manufacturer
  • 37. Imagine… Collecting all drug discontinuations due to AEs… Interfacing seamlessly with any clinical system using ‘triggers’ to recognize AEs… Having as much safety data from source docs as we do claims data… Having a denominator from each reporting institution…
  • 38. This is not your fathers spontaneous reporting…
  • 39. By utilizing digitized healthcare data and new business models we can develop, in the near future, a new type of ‘triggered reporting’ system, which is pervasive, efficient, delivers high quality information, and improves patient safety.